Deregulation of microRNAs by HIV-1 Vpr Protein Leads to the Development of Neurocognitive Disorders

被引:38
|
作者
Mukerjee, Ruma [1 ]
Chang, J. Robert [1 ]
Del Valle, Luis [3 ,4 ]
Bagashev, Asen [1 ]
Gayed, Monika M. [1 ]
Lyde, Randolph B. [1 ]
Hawkins, Brian J. [5 ]
Brailoiu, Eugen [2 ]
Cohen, Eric [6 ,7 ]
Power, Chris [8 ,9 ]
Azizi, S. Ausim [1 ]
Gelman, Benjamin B. [10 ,11 ]
Sawaya, Bassel E. [1 ]
机构
[1] Temple Univ, Sch Med, Mol Studies Neurodegenerat Dis Lab, Dept Neurol, 3420 N Broad St MRB 719, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Mol Studies Neurodegenerat Dis Lab, Dept Pharmacol, Philadelphia, PA 19140 USA
[3] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, Dept Med,Sect Hematol Oncol, New Orleans, LA 70112 USA
[4] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, Dept Pathol, New Orleans, LA 70112 USA
[5] Univ Washington, Mitochondria & Metab Ctr, Seattle, WA 98109 USA
[6] Univ Montreal, IRCM, Quebec City, PQ, Canada
[7] Univ Montreal, Dept Microbiol & Immunol, Quebec City, PQ, Canada
[8] Univ Alberta, Dept Med Neurol Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada
[9] Univ Alberta, Dept Psychiat, Edmonton, AB T6G 2S2, Canada
[10] Univ Texas, Med Branch, Texas NeuroAIDS Res Ctr, Dept Pathol & Neurosci, Galveston, TX 77555 USA
[11] Univ Texas, Med Branch, Texas NeuroAIDS Res Ctr, Dept Cell Biol, Galveston, TX 77555 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; NEURONAL INJURY; RECEPTOR; BRAIN; EXPRESSION; APOPTOSIS; INVOLVEMENT; DEATH; STEM; P53;
D O I
10.1074/jbc.M111.241547
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Studies have shown that HIV-infected patients develop neurocognitive disorders characterized by neuronal dysfunction. The lack of productive infection of neurons by HIV suggests that viral and cellular proteins, with neurotoxic activities, released from HIV-1-infected target cells can cause this neuronal deregulation. The viral protein R (Vpr), a protein encoded by HIV-1, has been shown to alter the expression of various important cytokines and inflammatory proteins in infected and uninfected cells; however the mechanisms involved remain unclear. Using a human neuronal cell line, we found that Vpr can be taken up by neurons causing: (i) deregulation of calcium homeostasis, (ii) endoplasmic reticulum-calcium release, (iii) activation of the oxidative stress pathway, (iv) mitochondrial dysfunction and v-synaptic retraction. In search for the cellular factors involved, we performed microRNAs and gene array assays using human neurons (primary cultures or cell line, SH-SY5Y) that we treated with recombinant Vpr proteins. Interestingly, Vpr deregulates the levels of several microRNAs (e. g. miR-34a) and their target genes (e. g. CREB), which could lead to neuronal dysfunctions. Therefore, we conclude that Vpr plays a major role in neuronal dysfunction through deregulating microRNAs and their target genes, a phenomenon that could lead to the development of neurocognitive disorders.
引用
收藏
页码:34976 / 34985
页数:10
相关论文
共 50 条
  • [41] Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
    Amila Omeragic
    Olanre Kayode
    Md Tozammel Hoque
    Reina Bendayan
    Fluids and Barriers of the CNS, 17
  • [42] IDENTIFICATION OF HIV-1 VPR PRODUCT AND FUNCTION
    COHEN, EA
    TERWILLIGER, EF
    JALINOOS, Y
    PROULX, J
    SODROSKI, JG
    HASELTINE, WA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 (01): : 11 - 18
  • [43] HIV-1 Vpr: Regulator of Viral Survival
    Thieu, Khanh P.
    Morrow, Matthew P.
    Shedlock, Devon J.
    Schoenly, Kimberly A.
    Mallilankaraman, Karthikbabu
    Choo, Andrew Y.
    Fagone, Paolo
    Weiner, David B.
    Muthumani, Karuppiah
    CURRENT HIV RESEARCH, 2009, 7 (02) : 153 - 162
  • [44] Evidence for a cytopathogenicity determinant in HIV-1 Vpr
    Somasundaran, M
    Sharkey, M
    Brichacek, B
    Luzuriaga, K
    Emerman, M
    Sullivan, JL
    Stevenson, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (14) : 9503 - 9508
  • [45] Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
    Omeragic, Amila
    Kayode, Olanre
    Hoque, Md Tozammel
    Bendayan, Reina
    FLUIDS AND BARRIERS OF THE CNS, 2020, 17 (01)
  • [46] Intranuclear binding by the HIV-1 regulatory protein VPR is dependent on cytosolic factors
    Jans, DA
    Jans, P
    Jülich, T
    Briggs, LJ
    Xiao, CY
    Piller, SC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (03) : 1055 - 1062
  • [47] Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis
    Pomerantz, RJ
    DNA AND CELL BIOLOGY, 2004, 23 (04) : 227 - 238
  • [48] Neurorestoration of Sustained Attention in a Model of HIV-1 Associated Neurocognitive Disorders
    Moran, Landhing M.
    McLaurin, Kristen A.
    Booze, Rosemarie M.
    Mactutus, Charles F.
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2019, 13
  • [50] Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders
    Teresa H. Evering
    Current HIV/AIDS Reports, 2018, 15 : 72 - 83